SCHEMBL2019846

SCHEMBL2019846

COc1ccc(Cc2cn3c(N)nnc3c(N)n2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
HPGD P15428 1/20 0.48
DHFR P00374 1/20 0.46
HTT P42858 1/20 0.46
CA2 P00918 1/20 0.45
MIF P14174 1/20 0.45
HSP90AB1 P08238 1/20 0.43
CYP19A1 P11511 1/20 0.40
GAA P10253 2/20 0.39
POLB P06746 1/20 0.39
MPI P34949 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
PDE2A O00408 1/20 0.39
ABCC4 O15439 1/20 0.39
USP2 O75604 1/20 0.39
PDE5A O76074 1/20 0.39
ABCB11 O95342 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2025901 0.89 CYP19A1 (0.48) ALDH1A1HPGDDHFRHTTHSP90AB1
SCHEMBL2022025 0.76 ADORA2A (0.62) ALDH1A1DHFRMIFKDM4E
SCHEMBL2018800 0.75 DHFR (0.46) ALDH1A1HPGDDHFRCYP2D6TSHR
SCHEMBL2019661 0.72 CYP1A2 (0.45) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL2024812 0.69 ADORA2A (0.46) ALDH1A1CYP3A4ACHEKDM4E
SCHEMBL2021765 0.68 DHFR (0.43) DHFRHSP90AB1POLB
SCHEMBL2023558 0.68 DHFR (0.43) DHFRPOLBRAB9A
SCHEMBL2095593 0.66 CA2 (1.00) ALDH1A1HPGDCA2CYP19A1GAA
SCHEMBL12482181 0.66 APP (0.47) ALDH1A1HPGDHTTGAAPOLB
SCHEMBL2026371 0.66 HPSE (0.43) ALDH1A1DHFRCYP1A2CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329705-B2 Substituted triazolo-pyrazine compounds ARQULE, INC. (US) 2012-12-11 US disclosed
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds ARQULE, INC. (US) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160215-A1 Substituted Triazolo-Pyrazine Compounds MKI67, TP53, THPO ALDH1A1 1473/4885HPGD 255/4885DHFR 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.